CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 301 enrolled
Drug / intervention
new silicone hydrogel daily disposable multifocal contact lens, the Bausch + Lomb (kalifilcon A) Daily Disposable Multifocal Contact Lensdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05660577
NCT05660577N/ACompleted
CompareCT.gov

A Study to Evaluate the Product Performance of a New Silicone Hydrogel Multifocal Contact Lens

Bausch & Lomb Incorporated·interventional·Posted Dec 21, 2022·Updated Apr 9, 2024

In Brief

A clinical study evaluating new silicone hydrogel daily disposable multifocal contact lens, the Bausch + Lomb (kalifilcon A) Daily Disposable Multifocal Contact Lens for Myopia and Hyperopia and Presbyopia. Completed, enrolled 301 participants across 20 sites.

Detailed Summary

The objective of this study is to evaluate the product performance of a new silicone hydrogel daily disposable multifocal contact lens, the Bausch + Lomb (kalifilcon A) Daily Disposable Multifocal Contact Lens, when worn by current soft contact lens wearers on a daily disposable wear basis

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia and Hyperopia and Presbyopia
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedDec 21, 2022
Enrollment StartNov 7, 2022
Primary CompletionJan 16, 2023
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 3.5 years ago

Interventions

new silicone hydrogel daily disposable multifocal contact lens, the Bausch + Lomb (kalifilcon A) Daily Disposable Multifocal Contact Lensdevice

new silicone hydrogel daily disposable multifocal contact lens, the Bausch + Lomb (kalifilcon A) Daily Disposable Multifocal Contact Lens